After President Donald Trump signed an executive order to transform kidney treatment in the U.S., Humana’s stock price increased to $291.28 July 12. At market close July 12, Humana’s share price was up 10 percent from its closing share on July 8.
The share price marked Humana’s highest gain since Feb. 26, when the price closed at $302.35. That high came at the end of a historic run for the company’s shares, according to Louisville Business First.
Read the full report here.
More articles on payers:
UnitedHealth needs to shore up mental health coverage, plaintiffs argue
Las Vegas hospital will have to contract with Medicare, Medicaid by 2021
Massachusetts residents bought fake health insurance, state says
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
